WASHINGTON ? The Food and Drug Administration says it approved a new HIV drug from Johnson & Johnson for patients who have not been treated with other medications for the virus. The once-a-day pill Edurant works by blocking the virus from reproducing. It...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA approves new HIV drug from Johnson & Johnson
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account